Transcatheter tricuspid valve replacement for functional tricuspid regurgitation after left-sided valve surgery: A single-center experience.
Yiwei WangMengen ZhaiYu MaoTingting YangGuangyu ZhuYang LiuJian YangPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2024)
The Lux-Valve system was found to be safe and effective for treating FTR after LSVS. It resulted in positive early outcomes, including a significant reduction in FTR, improved functional status, and enhanced quality of life, especially in high-risk patients.
Keyphrases
- aortic valve
- aortic stenosis
- ejection fraction
- mitral valve
- transcatheter aortic valve replacement
- end stage renal disease
- left ventricular
- minimally invasive
- type diabetes
- prognostic factors
- coronary artery bypass
- skeletal muscle
- metabolic syndrome
- insulin resistance
- patient reported
- percutaneous coronary intervention